Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksImmupharma Share News (IMM)

Share Price Information for Immupharma (IMM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 2.01
Bid: 1.84
Ask: 1.96
Change: -0.14 (-6.86%)
Spread: 0.12 (6.522%)
Open: 2.00
High: 2.01
Low: 2.00
Prev. Close: 2.04
IMM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Mon, 21st Jun 2021 16:11

Tuesday 22 June 
Caerus Mineral Resources PLCAGM
Coca-Cola HBC AGAGM
Cora Gold LtdAGM
EPE Special Opportunities LtdAGM
Frenkel Topping Group PLCAGM
Intelligent Ultrasound Group PLCAGM
RTW Venture Fund LtdAGM
Surgical Innovations Group PLCAGM
Urban Exposure PLCGM re cancellation from AIM, liquidation
Wednesday 23 June 
Angling Direct PLCAGM
Clontarf Energy PLCAGM
Dignity PLCAGM - dispute with Phoenix UK Fund, which wants to replace chair
Directa Plus PLCAGM
ECSC Group PLCAGM
Harbour Energy PLCAGM
Incanthera PLCAGM
IQE PLCAGM
JKX Oil & Gas PLCAGM
LSL Property Services PLCAGM
Oriole Resources PLCAGM
Pebble Beach Systems Group PLCAGM
PetroTal CorpAGM
Premier Oil PLCAGM
Touchstar PLCAGM
Velocys PLCAGM
Vertu Motors PLCAGM
Woodbois LtdAGM
Thursday 24 June 
Argo Blockchain PLCAGM
Atalaya Mining PLCAGM
Boston International Holdings PLCGM
Fresnillo PLCAGM
Gemfields Group LtdAGM
Incanthera PLCAGM
Itaconix PLCAGM
Kavango Resources PLCAGM
NB Distressed Debt Investment Fund LtdAGM
Science in Sport PLCAGM
Scottish Mortgage Investment Trust PLCAGM
Serica Energy PLCAGM
STM Group PLCAGM
Tandem Group PLCAGM
THG PLCAGM
Westminster Group PLCAGM
Friday 25 June 
Cadogan Petroleum PLCAGM
Entain PLCAGM
Gulf Marine Services PLCGM re share placing
HeiQ PLCAGM
Hemogenyx Pharmaceuticals PLCAGM
Inspiration Healthcare Group PLCAGM
Norman Broadbent PLCAGM
SDX Energy PLCAGM
Serabi Gold PLCAGM
Tesco PLCAGM
Tiziana Life Sciences PLCAGM
Monday 28 June 
Anglo-Eastern Plantations PLCAGM
Avacta Group PLCAGM
City Pub Group PLCAGM
Escape Hunt PLCAGM
Eurasia Mining PLCAGM
Futura Medical PLCAGM
Gulf Marine Services PLCAGM
Hiscox LtdEGM
ICG-Longbow Senior Secured UK Property Debt Investments LtdAGM
ImmuPharma PLCAGM
Kanabo Group PLCAGM
Longboat Energy PLCGM re reverse takeover
Pennon Group PLCGM re share consolidation & changes to AoA
Symphony Environment Technologies PLCAGM
Volvere PLCAGM
Zinnwald Lithium PLCAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
13 Dec 2019 12:12

ImmuPharma To List On Life Sciences Heavy Brussels Index

ImmuPharma To List On Life Sciences Heavy Brussels Index

Read more
11 Dec 2019 14:54

ImmuPharma says not looking to raise funds

(Sharecast News) - AIM-listed specialist drug discovery and development company ImmuPharma insisted on Wednesday that it is not looking to raise funds.

Read more
11 Dec 2019 14:03

ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise

ImmuPharma Confirms It Will Not Raise Funds Despite Share Price Rise

Read more
28 Nov 2019 16:26

ImmuPharma shares soar as it teams up with Avion on Lupuzor

(Sharecast News) - Specialist drug discovery and development company ImmuPharma announced a licence and development agreement with Avion Pharmaceuticals on Thursday, for the exclusive rights to 'Lupuzor' in the United States.

Read more
28 Nov 2019 12:02

Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion

Immupharma Shares Take Off On Lupuzor US Licencing Deal With Avion

Read more
28 Nov 2019 07:28

ImmuPharma licenses lupus drug Lupuzor to Avion in the United States

LONDON, Nov 28 (Reuters) - British pharmaceutical firm ImmuPharma said on Thursday it had signed a licensing and development agreement for Lupuzor, a first-in-class treatment for auto-immune disease Lupus, with U.S. company Avion Pharmaceuticals....

Read more
30 Sep 2019 10:40

ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval

ImmuPharma Loss Narrows Slightly, Focus On Lupuzor Regulatory Approval

Read more
28 Jun 2019 12:01

Immupharma Study Demonstrates Robust Safety Profile Of Lupuzor

(Alliance News) - Immupharma PLC on Friday reported analysis of the results from the study of Lupuzor, its lead programme for the potential breakthrough compound for Lupus, a potentially life drug

Read more
28 Jun 2019 10:27

ImmuPharma pleased with Lupuzor open-label study results

(Sharecast News) - Specialist drug discovery and development company ImmuPharma released the analysis of results from the open-label six month extension study from its original pivotal phase 3 trial of 'Lupuzor' on Friday.

Read more
26 Jun 2019 11:15

Immupharma raises ?2.66m from subscription agreement with institutional investor

(Sharecast News) - Drug discovery and development specialist Immupharma raised roughly £2.66m via a subscription agreement with institutional investor Lanstead Capital on Wednesday.

Read more
26 Jun 2019 10:14

Immupharma Raises GBP2.7 Million From Share Subscription With Lanstead

(Alliance News) - Immupharma PLC on Wednesday announced a 26.6 million share subscription to raise around GBP2.7 million at a price of 10 pence per share.The drug discovery and development

Read more
24 May 2019 11:47

Immupharma 2018 Loss Widens Amid Placing; Progresses On Pipeline

LONDON (Alliance News) - Drug development firm Immupharma PLC said Friday its 2018 loss widened amid share placing costs, whilst it continued to make "key" progress in its 2018, pretax a

Read more
7 May 2019 11:06

ImmuPharma Exploring European Listing For Combined French Businesses (ALLIPO)

LONDON (Alliance News) - ImmuPharma PLC is exploring the merger and possible separate listing of two French subsidiaries, it said Tuesday.Elro Pharma Sarl and Ureka Sarl are currently on a

Read more
1 Apr 2019 14:07

ImmuPharma Loses Exclusivity Period For Talks With Incanthera

LONDON (Alliance News) - ImmuPharma PLC on Monday said proposed partner Incanthera Ltd can now talk with other potential parties after an exclusivity period ended.In September, ImmuPharma a

Read more
14 Mar 2019 11:04

ImmuPharma struggles to convince investors in latest update

(Sharecast News) - Shares in ImmuPharma fell even further on Thursday, as the ailing drug development company struggled to give shareholders some reassurance about its future in an update.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.